Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000708532 | SCV000837642 | pathogenic | Hereditary breast ovarian cancer syndrome | 2022-09-03 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 19-20 of the BRCA2 gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in BRCA2 are known to be pathogenic (PMID: 20104584). A similar copy number variant has been observed in individual(s) with hereditary breast and/or ovarian cancer and prostate cancer (PMID: 17688236, 18445692, 25678442, 28595730). For these reasons, this variant has been classified as Pathogenic. |